Vibriocidal antibody responses to a bivalent killed whole-cell oral cholera vaccine in a phase III trial in Kolkata, India.

Vibriocidal antibody responses to a bivalent killed whole-cell oral cholera vaccine in a phase III trial in Kolkata, India.

During the development of a vaccine, identification of the correlates of protection is of paramount importance for establishing an objective criterion for the protective performance of the vaccine. However, the ascertainment of correlates of immunity conferred by any vaccine is a difficult task.Whil...

Full description

Bibliographic Details
Main Authors: Suman Kanungo, Anna Lena Lopez, Mohammad Ali, Byomkesh Manna, Deok Ryon Kim, Tanmay Mahapatra, Jan Holmgren, Mandeep S Dhingra, Thomas F Weirzba, G Balakrish Nair, Sujit K Bhattacharya, John D Clemens, Dipika Sur
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4011749?pdf=render

Internet

http://europepmc.org/articles/PMC4011749?pdf=render

Similar Items